EKF Diagnostics completes Quotient Diagnostics acquisition
EKF Diagnostics, the point of care diagnostics company, reported that they have completed the acquisition of Quotient Diagnostics (as reported 23 September 2010 edition of Weekly Update). Quotient Diagnostics developed two proprietary diabetes (Hb1Ac) point of care diagnostic products which are complementary to EKF's existing products.
Filed Under: Acquisition, Acquisitions, Diagnostics, Medical Equipment, Medical, Medical Devices, Medical Component Engineering,
Disclaimer:
This note was prepared by LCF Research Limited using information provided by the subject company’s management or publically available news sources. No representations are made nor warranties given (express or implied) in relation to accuracy and completeness. This document is not an invitation to invest in the subject company and does not purport to contain all the necessary information that a prospective investor might require. LCF Research Limited recommends prospective investors to conduct their own thorough independent analysis of the subject company and the information contained in this note or referred to above.
EKF Diagnostics Holdings Plc, formerly International Brand Licensing plc, designs, develops, manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company is focused within the In-Vitro Diagnostic devices (IVD) market place. Other services include the servicing and distribution of other Company products under separate distribution agreements. The Company operates in Germany, United Kingdom, Ireland, Poland and Russia. On July 2, 2010, the Company acquired 100% interest of EKF-diagnostic Gmbh. On October 4, 2010, the Company acquired 100% of the share capital of Quotient Diagnostics Limited. On December 2, 2010, the Company acquired 100% of the share capital of Argutus Medical Limited. During 2010, the Company discontinued its licensing business and disposed of its portfolio of sports and lifestyle brands. In March 2012, the Company sold International Brand Licensing AG (IBL AG). more »
